Neuropathy as a potential complication of levodopa use in Parkinson's disease: A pharmacological and pharmacovigilance point of view

Movement Disorders

Volumn 25, Issue 5, 2010, Pages 660-661

  Montastruc, Jean Louis ^a,b   Danton, Anne Charlotte ^a   Durrieu, Genevieve ^a   Lacroix, Isabelle ^a   Olivier, Pascale ^a   Sommet, Agnès ^a   Senard, Jean Michel ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEPRIDIL; CALCIUM PHOSPHATE; FUROSEMIDE; GLYCERYL TRINITRATE; LEVODOPA; NAVELBINE; PIRIBEDIL;

ANGINA PECTORIS; BLADDER CANCER; DRUG LEGISLATION; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; HYPERTENSION; LETTER; METASTASIS; NEUROPATHY; OSTEOPOROSIS; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORY NEUROPATHY;

ANTIPARKINSON AGENTS; DATABASES, FACTUAL; HUMANS; LEVODOPA; PARKINSON DISEASE; POLYNEUROPATHIES;

EID: 77951231370     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22878     Document Type: Letter

References (4)

1. Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D. Neuropathy as a potential complication of levodopa use in Parkinson's disease. Mov Disord 2008;23:1850-1859.
2. Durrieu G, Lacroix I, Olivier P, Sommet A, Sénard JM, Montastruc JL;the French Association of Regional PharmacoVigilance Centres. Drug-related neuropathies: analysis of the French Adverse Drug Reaction Database 1995-2005. Presse Med 2008;37:935-942.
3. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputation of unexpected or toxic effects of drugs; actualization of the method used in France. Therapie 1985;40:111-118.
4. WHO. International monitoring of adverse reactions to drugs: adverse reaction terminology. Uppsala: WHO collaborating Centre for International Drug Monitoring; 1992.